fingolimod hydrochloride has been researched along with Sepsis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Doi, Y; Ide, T; Isobe, R; Jinno, R; Kawabe, Y; Muramatsu, E; Ritsuno, Y; Sakurai, A; Sasaki, T; Tsutsumi, Y | 1 |
Han, Y; Kuai, F; Su, J; Wang, L; Wang, Y; Zhou, S | 1 |
Abassi, T; Berdyshev, E; Bittman, R; Dudek, SM; Garcia, JG; Huang, LS; Jacobson, JR; Mathew, B; Moreno-Vinasco, L; Natarajan, V; Wang, L; Weichselbaum, R; Zhao, Y | 1 |
Axelberg, H; Grände, PO; Lundblad, C | 1 |
Bauer, M; Benetti, E; Coldewey, SM; Collino, M; Huwiler, A; Pfeilschifter, J; Sponholz, C; Thiemermann, C | 1 |
Enderes, J; Heidecke, CD; Müller, J; Schulze, T; Tran, BT; van der Linde, J; von Bernstorff, W | 1 |
Gräler, MH; Hemdan, NY; Reimann, CM; Weigel, C | 1 |
1 review(s) available for fingolimod hydrochloride and Sepsis
Article | Year |
---|---|
Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Biomarkers; Capillary Permeability; Fingolimod Hydrochloride; Humans; Lung; Lysophospholipids; Membrane Proteins; Nerve Tissue Proteins; Phosphotransferases (Alcohol Group Acceptor); Pneumonia; Propylene Glycols; Receptors, Lysosphingolipid; Sepsis; Sphingosine; Transferases (Other Substituted Phosphate Groups); Translational Research, Biomedical | 2013 |
6 other study(ies) available for fingolimod hydrochloride and Sepsis
Article | Year |
---|---|
Periprosthetic joint infection due to Mycoplasma hominis in a multiple sclerosis patient treated with fingolimod.
Topics: Anti-Infective Agents; Arthritis, Infectious; Fingolimod Hydrochloride; Humans; Male; Middle Aged; Multiple Sclerosis; Mycoplasma hominis; Mycoplasma Infections; Prosthesis-Related Infections; Sepsis; Sphingosine-1-Phosphate Receptors | 2022 |
Exploring the Protective Role and the Mechanism of Sphingosine 1 Phosphate in Endotoxic Cardiomyocytes.
Topics: Animals; Apoptosis; Cell Line; Cytokines; Endotoxins; Fingolimod Hydrochloride; Lysophospholipids; MAP Kinase Signaling System; Myocytes, Cardiac; NF-kappa B; Rats; Sepsis; Sphingosine | 2019 |
Treatment with the sphingosine-1-phosphate analogue FTY 720 reduces loss of plasma volume during experimental sepsis in the rat.
Topics: Animals; Capillary Leak Syndrome; Capillary Permeability; Cecum; Disease Models, Animal; Diuresis; Drug Evaluation, Preclinical; Edema; Endothelium, Vascular; Fingolimod Hydrochloride; Hematocrit; Hemodynamics; Hemoglobins; Intestinal Perforation; Lysophospholipids; Male; Plasma Volume; Propylene Glycols; Random Allocation; Rats; Rats, Sprague-Dawley; Sepsis; Sphingosine | 2013 |
Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Fingolimod Hydrochloride; Heart; Humans; Inflammation; Lipopolysaccharides; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardium; Peptidoglycan; Phosphatidylinositol 3-Kinases; Phosphorylation; Pilot Projects; Receptors, Lysosphingolipid; Sepsis; Sphingosine | 2016 |
FTY720-Induced Lymphopenia Does Not Aggravate Mortality in a Murine Model of Polymicrobial Abdominal Sepsis.
Topics: Animals; Disease Models, Animal; Female; Fingolimod Hydrochloride; Flow Cytometry; Lymphopenia; Mice; Mice, Inbred C57BL; Peritonitis; Sepsis | 2017 |
Modulating sphingosine 1-phosphate signaling with DOP or FTY720 alleviates vascular and immune defects in mouse sepsis.
Topics: Animals; Capillary Permeability; Cells, Cultured; Cytokines; Fingolimod Hydrochloride; Immunomodulation; Lysophospholipids; Membrane Proteins; Mice; Mice, Inbred C57BL; Phosphoric Monoester Hydrolases; Pyridoxine; Receptors, Lysosphingolipid; Sepsis; Signal Transduction; Sphingosine; Vascular Endothelial Growth Factor A | 2016 |